Abstract
EUS has evolved from EUS imaging, to EUS-guided FNA, and now to EUS-guided fine needle injection (FNI). This advancement has paved the way for ”Interventional EUS” [ 1 ]. EUS-guided FNI includes delivery of contrast agents with subsequent drainage/anastomosis, pre-EMR solution, botulinum toxin, neurolytic agents (including intra-ganglion injections), sclerosing solutions/glue, radiofrequency energy, radioactive and inert seeds, light-activating laser, and a growing number of anti-tumor agents. These will all be addressed in this update.